BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26308531)

  • 1. Musashi-2 Silencing Exerts Potent Activity against Acute Myeloid Leukemia and Enhances Chemosensitivity to Daunorubicin.
    Han Y; Ye A; Zhang Y; Cai Z; Wang W; Sun L; Jiang S; Wu J; Yu K; Zhang S
    PLoS One; 2015; 10(8):e0136484. PubMed ID: 26308531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Musashi2 modulates K562 leukemic cell proliferation and apoptosis involving the MAPK pathway.
    Zhang H; Tan S; Wang J; Chen S; Quan J; Xian J; Zhang Ss; He J; Zhang L
    Exp Cell Res; 2014 Jan; 320(1):119-27. PubMed ID: 24076374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
    J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling.
    Xiao Y; Deng T; Ming X; Xu J
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of musashi-2 gene in leukemia stem cells from acute myeloid leukemia patients].
    Ye AF; Han YX; Zhang SH; Li HY; Chen CQ; Wu JB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1235-8. PubMed ID: 25338564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of spongean alkaloids on mechanisms of cell death, cell cycle progression and DNA damage response (DDR) of acute myeloid leukemia (AML) cells.
    Stuhldreier F; Kassel S; Schumacher L; Wesselborg S; Proksch P; Fritz G
    Cancer Lett; 2015 May; 361(1):39-48. PubMed ID: 25697484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells.
    Bu S; Xie Q; Chang W; Huo X; Chen F; Ma X
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1531-7. PubMed ID: 23702031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/Notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia.
    Li F; Han Y; Chen R; Jiang Y; Chen C; Wang X; Zhou J; Xu Q; Jiang S; Zhang S; Yu K; Zhang S
    J Transl Med; 2023 May; 21(1):309. PubMed ID: 37149661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulated A20 promotes proliferation, regulates cell cycle progression and induces chemotherapy resistance of acute lymphoblastic leukemia cells.
    Chen S; Xing H; Li S; Yu J; Li H; Liu S; Tian Z; Tang K; Rao Q; Wang M; Wang J
    Leuk Res; 2015 Sep; 39(9):976-83. PubMed ID: 26159495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
    Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
    J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells.
    Karami H; Baradaran B; Esfahani A; Estiar MA; Naghavi-Behzad M; Sakhinia M; Sakhinia E
    Asian Pac J Cancer Prev; 2013; 14(12):7719-24. PubMed ID: 24460358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia.
    Minuesa G; Albanese SK; Xie W; Kazansky Y; Worroll D; Chow A; Schurer A; Park SM; Rotsides CZ; Taggart J; Rizzi A; Naden LN; Chou T; Gourkanti S; Cappel D; Passarelli MC; Fairchild L; Adura C; Glickman JF; Schulman J; Famulare C; Patel M; Eibl JK; Ross GM; Bhattacharya S; Tan DS; Leslie CS; Beuming T; Patel DJ; Goldgur Y; Chodera JD; Kharas MG
    Nat Commun; 2019 Jun; 10(1):2691. PubMed ID: 31217428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin.
    Bollaert E; Claus M; Vandewalle V; Lenglez S; Essaghir A; Demoulin JB; Havelange V
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.
    Heyes E; Schmidt L; Manhart G; Eder T; Proietti L; Grebien F
    Leukemia; 2021 Sep; 35(9):2526-2538. PubMed ID: 33623142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer.
    Sheng W; Dong M; Chen C; Wang Z; Li Y; Wang K; Li Y; Zhou J
    FASEB J; 2017 Jun; 31(6):2429-2438. PubMed ID: 28223335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
    Lin M; Hu J; Liu T; Li J; Chen B; Chen X
    Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of myeloid cell leukemia-1 by small interfering RNA improves chemosensitivity to etoposide in u-937 leukemic cells.
    Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Karimi P; Othman F
    J Biol Regul Homeost Agents; 2016; 30(1):55-65. PubMed ID: 27049076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-33b regulates sensitivity to daunorubicin in acute myelocytic leukemia by regulating eukaryotic translation initiation factor 5A-2.
    Liu Y; Lei P; Qiao H; Sun K; Lu X; Bao F; Yu R; Lian C; Li Y; Chen W; Xue F
    J Cell Biochem; 2020 Jan; 121(1):385-393. PubMed ID: 31222822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.
    Palacios F; Yan XJ; Ferrer G; Chen SS; Vergani S; Yang X; Gardner J; Barrientos JC; Rock P; Burack R; Kolitz JE; Allen SL; Kharas MG; Abdel-Wahab O; Rai KR; Chiorazzi N
    Leukemia; 2021 Apr; 35(4):1037-1052. PubMed ID: 33504942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.